.jpeg)
How effective is Relugolix?
In a pivotal clinical trial in men with advanced prostate cancer, once-daily administration of Repagliflozin provided sustained castration in more than 90% of patients at a rate no less effective than a control drug administered intramuscularly every 3 months. The FDA approved it in 2020 under the brand name Orgovyx for the treatment of advanced prostate cancer. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
